Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 408.31M P/E - EPS this Y 0.40% Ern Qtrly Grth -
Income -139.21M Forward P/E -3.50 EPS next Y 4.80% 50D Avg Chg 6.00%
Sales - PEG -0.88 EPS past 5Y - 200D Avg Chg -2.00%
Dividend N/A Price/Book 2.37 EPS next 5Y 3.40% 52W High Chg -58.00%
Recommedations 1.80 Quick Ratio 11.34 Shares Outstanding 68.39M 52W Low Chg 28.00%
Insider Own 24.43% ROA -36.22% Shares Float 41.49M Beta 2.27
Inst Own 42.10% ROE -70.90% Shares Shorted/Prior 5.87M/4.68M Price 8.95
Gross Margin - Profit Margin - Avg. Volume 289,617 Target Price 38.22
Oper. Margin - Earnings Date Oct 31 Volume 309,184 Change 0.00%
About COMPASS Pathways Plc - American

COMPASS Pathways plc operates as a mental health care company in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that is in Phase III clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder and anorexia nervosa. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. COMPASS Pathways plc was incorporated in 2020 and is headquartered in London, the United Kingdom.

COMPASS Pathways Plc - American News
11/14/24 Compass Pathways to participate in Stifel 2024 Healthcare Conference
11/02/24 Compass Pathways cuts 30% of workforce on Phase 3 trial delays
11/01/24 Compass Pathways PLC (CMPS) Q3 2024 Earnings Call Highlights: Navigating Financial Challenges ...
10/31/24 Compass Pathways Plc (CMPS) Q3 2024 Earnings Call Transcript
10/31/24 Compass delays anticipated psilocybin readout, cuts staff
10/31/24 Compass Pathways Announces Third Quarter 2024 Financial Results and Business Updates
10/24/24 Compass Pathways to Announce Third Quarter Financial Results on October 31, 2024
06:00 AM Compass Pathways to Participate in Cowen Psychedelics and Novel Mechanisms in Neuropsychiatry Summit
08/28/24 Compass Pathways to participate in three investor conferences in September
08/25/24 Morgan Stanley Predicts up to 220% Jump for These 2 ‘Strong Buy’ Stocks
08/19/24 More promise for psilocybin in depression but safety remains a concern
08/06/24 COMPASS Pathways to participate in Canaccord Genuity 44th Annual Growth Conference
08/01/24 Compass Pathways Plc (CMPS) Q2 2024 Earnings Call Transcript
08/01/24 Compass Pathways announces second quarter 2024 financial results and business highlights
07/28/24 Weekly Roundup on the Cannabis Sector & Psychedelic Sector
07/24/24 Compass Pathways to announce second quarter financial results on August 1, 2024
07/08/24 3 Next-Gen Drug Stocks Exploring Psychedelic Frontiers
07/02/24 3 Psychedelic Stocks to Buy on the Dip: Summer 2024
06/26/24 Compass Pathways appoints Lori Englebert as Chief Commercial Officer
06/24/24 Compass Pathways to participate in upcoming H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference
CMPS Chatroom

User Image 89P413 Posted - 14 hours ago

$CBDL CEO keeps delivering! MORE NEXT WEEK! $MSOS $CGC $TLRY $CMPS

User Image sellhigh69 Posted - 17 hours ago

$CMPS does anyone know if the stock is getting diluted?

User Image Cashtonll2 Posted - 17 hours ago

Thank god sector has $ATAI so far holding its pop past two weeks $CMPS $CYBN

User Image wat92098 Posted - 17 hours ago

$CMPS Just a reminder, Atai has a huge stake in this

User Image SanKish Posted - 1 day ago

$CMPS wondering if I should buy more for DCA. I am already down 2K on this.

User Image BobJohnBuoy666 Posted - 1 day ago

$CMPS added. More pain to come. Market will punish this stock for delaying results.

User Image aaronmag13 Posted - 1 day ago

$CMPS check out the fintel. Steve cohen is here now with 58,900 shares and Ken griffin is now at 5.4 million shares plus a ton of good new positions opened on the 11/14 filings.

User Image ABELTR Posted - 1 day ago

$CMPS Kennedy is not right. He is one brick shy of a load. Forget him

User Image ABELTR Posted - 1 day ago

$CMPS right on

User Image aaronmag13 Posted - 1 day ago

$CMPS people, please stop with the RFK assumptions. This dude is more than likely not getting in. The company delayed the data more than likely because they didn’t want to compromise the study after the Lykos rejection and they are framing things better based off the rejection. The delay was a good thing. RFK is not going to save the stock price nor is he connected to it.

User Image sellhigh69 Posted - 1 day ago

$CMPS what the heck’s going on I thought Kennedy liked out his mushroom stuff

User Image jeinvestments Posted - 1 day ago

$CMPS Do you think they intentionally delayed phase 3 readings to ensure it aligns with when RFK is in house?

User Image thebadfish843 Posted - 1 day ago

$CMPS what a dickhead…

User Image Spammified Posted - 2 days ago

$CMPS wow just spotted we're almost at top line results from phase 3... Time to average down... Funds transferred in... Buy orders will be set going down from 5 to 4 for accumulation. This is coiled up ready...

User Image PsychedStocks Posted - 3 days ago

RFK Jr. Advocates For Regulated Psychedelics In Mental Health $CYBN $CMPS $ATAI $MNMD $TSLA https://www.oann.com/video/oan-contribution/rfk-jr-advocates-for-regulated-psychedelics-in-mental-health/

User Image ABELTR Posted - 3 days ago

$CMPS huck RFK. Just make the product, get it passed, create the very best sales team.

User Image PsychedStocks Posted - 3 days ago

$CYBN $CMPS $ATAI $MNMD $SPY Cybin's psychedelic depression drug reduces 12-month symptom severity https://www.fiercebiotech.com/biotech/cybin-sees-slight-stock-bump-after-psychedelic-depression-drug-reduces-12-month-symptom

User Image aaronmag13 Posted - 3 days ago

$CMPS is this about to give me low 4s today?

User Image PsychedStocks Posted - 4 days ago

$CYBN $CMPS $ATAI $MNMD the whole sector sold the news today. The whales are still coming. Be prepared!

User Image tomtom101 Posted - 4 days ago

$CMPS interesting dip. Guess they want me get some.

User Image Cashtonll2 Posted - 4 days ago

How many times do people need to watch stocks in this sector get a massive pop then sell off and give it all away plus some. It’s the sector it’s not just one name $ATAI $CMPS $CYBN $MNMD

User Image aaronmag13 Posted - 4 days ago

$ATAI $CMPS $CYBN $MNMD $SPY RFK Jr is more than likely not getting confirmed by Congress for this position. He doesn’t have the job yet. Don’t buy psychedelics because you THINK that RFK may get appointed to HHS.

User Image firetypecracker Posted - 4 days ago

$TSLA $CMPS $MNMD $CYBN $ATAI HC Wainwright & Co. Reiterates Buy on Cybin, Maintains $190 Price Target

User Image Xaeraiae28 Posted - 4 days ago

$ATAI $CMPS $CYBN $MNMD $SPY so CYB003 is just an lab-improved psilocybin? Without the sickness and long time and “waves”? Basically without the flaws of shrooms. Interesting

User Image PsychedStocks Posted - 4 days ago

RFK Jr. announced as HHS Secretary This means the FDA will be forced to stop suppressing "alternative" medicines like psychedelics that are tested and proven to be effective $CYBN CYB003 12 month data extremely positive. 100% of participants responded to the treatment, with 71% achieving remission at the 12-month mark Phase 3 underway with FDA Breakthrough Therapy Designation FDA approval here seems likely $CMPS $MNMD $ATAI $SPY https://www.businesswire.com/news/home/20241118852918/en/Cybin-Reports-Positive-Phase-2-Data-for-CYB003-Demonstrating-Breakthrough-12-Month-Efficacy-in-Treating-Major-Depressive-Disorder

User Image PsychedStocks Posted - 4 days ago

$CYBN $CMPS $ATAI $MNMD $TSLA HC Wainwright & Co. Reiterates Buy on Cybin, Maintains $190 Price Target https://www.benzinga.com/news/24/11/42043033/hc-wainwright-co-reiterates-buy-on-cybin-maintains-190-price-target

User Image wat92098 Posted - 4 days ago

$CMPS someone’s accumulating big-time

User Image wat92098 Posted - 4 days ago

$ATAI $ATAI Has a very big stake in $CMPS!!! More psychedelics

User Image aaronmag13 Posted - 4 days ago

$CMPS retail fomoing into CYBN only to have it close red today or back below pre-data release levels tomorrow. I’m buying again here today.

User Image wat92098 Posted - 4 days ago

$CMPS And here we go, here comes the games, not selling one share

Analyst Ratings
RBC Capital Outperform Sep 10, 24
Cantor Fitzgerald Overweight Sep 9, 24
HC Wainwright & Co. Buy Aug 23, 24
Canaccord Genuity Buy Aug 2, 24
HC Wainwright & Co. Buy Jul 31, 24
RBC Capital Outperform Jul 23, 24
Cantor Fitzgerald Overweight Jun 21, 24
HC Wainwright & Co. Buy May 13, 24
Cantor Fitzgerald Overweight Apr 30, 24
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Goldsmith George Jay Director Director Jan 19 Sell 8.17 91,911 750,913 4,169,745 01/23/24
Malievskaia Ekaterina Director Director Jan 19 Sell 8.17 91,911 750,913 4,172,404 01/23/24
Malievskaia Ekaterina Director Director Dec 13 Sell 7.81 8,464 66,104 4,265,867 12/15/23
Goldsmith George Jay Director Director Dec 13 Sell 7.81 8,464 66,104 4,263,209 12/15/23
Malievskaia Ekaterina Chief Innovation Off.. Chief Innovation Officer Feb 01 Sell 12.48 12,744 159,045 4,284,201 03/31/22
Goldsmith George Jay Chief Executive Offi.. Chief Executive Officer Feb 01 Sell 12.48 12,744 159,045 4,268,197 03/31/22
Norton David Y Director Director Mar 29 Sell 12.48 3,384 42,232 20,356 03/31/22
Jenkins Annalisa Director Director Mar 29 Sell 12.48 3,384 42,232 20,356 03/31/22